Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies.
McKerrell T, Moreno T, Ponstingl H, Bolli N, Dias JM, Tischler G, Colonna V, Manasse B, Bench A, Bloxham D, Herman B, Fletcher D, Park N, Quail MA, Manes N, Hodkinson C, Baxter J, Sierra J, Foukaneli T, Warren AJ, Chi J, Costeas P, Rad R, Huntly B, Grove C, Ning Z, Tyler-Smith C, Varela I, Scott M, Nomdedeu J, Mustonen V, Vassiliou GS. McKerrell T, et al. Among authors: bloxham d. Blood. 2016 Jul 7;128(1):e1-9. doi: 10.1182/blood-2015-11-683334. Epub 2016 Apr 27. Blood. 2016. PMID: 27121471 Free PMC article. Clinical Trial.
PML protein analysis using imaging flow cytometry.
Grimwade L, Gudgin E, Bloxham D, Scott MA, Erber WN. Grimwade L, et al. Among authors: bloxham d. J Clin Pathol. 2011 May;64(5):447-50. doi: 10.1136/jcp.2010.085662. Epub 2010 Dec 22. J Clin Pathol. 2011. PMID: 21177751
Hairy cell leukemia - immunotargets and therapies.
Basheer F, Bloxham DM, Scott MA, Follows GA. Basheer F, et al. Immunotargets Ther. 2014 Jun 24;3:107-20. doi: 10.2147/ITT.S31425. eCollection 2014. Immunotargets Ther. 2014. PMID: 27471703 Free PMC article. Review.
Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma.
Anderson GSF, Ballester-Beltran J, Giotopoulos G, Guerrero JA, Surget S, Williamson JC, So T, Bloxham D, Aubareda A, Asby R, Walker I, Jenkinson L, Soilleux EJ, Roy JP, Teodósio A, Ficken C, Officer-Jones L, Nasser S, Skerget S, Keats JJ, Greaves P, Tai YT, Anderson KC, MacFarlane M, Thaventhiran JE, Huntly BJP, Lehner PJ, Chapman MA. Anderson GSF, et al. Among authors: bloxham d. Blood. 2022 Apr 21;139(16):2471-2482. doi: 10.1182/blood.2021015161. Blood. 2022. PMID: 35134130 Free PMC article.
115 results